Finger Tapping and Typing Kinematics as a Digital Biomarker

Fine motor control can be measured from how someone taps a screen or types on a keyboard, including passively from the typing they were doing anyway.

Status
Exploratory
Unit
derived kinematic score
Data type
Composite
Sensor
Touchscreen or keyboard timing
Worn
Phone

Evidence maturity

Graded with the V3 framework: whether the sensor measures accurately, whether the algorithm has been validated against a reference standard, and whether the measure has been shown to matter clinically.

Verification
Established
Analytical validation
Emerging
Clinical validation
Limited

Natural typing features have separated early Parkinson's disease from controls, and smartphone tapping batteries have been used in early phase trials. Most evidence is cross sectional rather than longitudinal, so responsiveness to treatment is not established.

What are Finger Tapping and Typing Kinematics

Finger tapping kinematics describe the speed, amplitude, rhythm and decay of repetitive finger movement. Typing kinematics describe the same underlying motor control derived from ordinary keyboard interaction, chiefly the time a key is held down and the interval between keystrokes.

The distinction between the two matters. A tapping task is an active assessment: the person is asked to perform, and the result depends on their effort and attention. Typing kinematics are passive: the data comes from typing the person was doing anyway, with no task, no prompt and no awareness of being measured. That makes it one of very few motor measures in this library that can be collected without asking anything of the participant, which removes both burden and the performance effect that active testing introduces.

How it is measured

Tap based measurement uses a touchscreen or a sensor on the finger and derives inter tap interval, tap amplitude, variability and the decrement across repetitions. Smartphone based test batteries designed for Parkinson's disease have included tapping tasks and have been evaluated in early phase trials.

Typing based measurement records keystroke timing during natural use. The key quantity is hold time, meaning how long a key stays pressed, and its variability. Analyses of natural typing have distinguished people with early Parkinson's disease from controls using these features alone, and large scale smartphone research platforms have collected tapping and related motor data from tens of thousands of participants.

Both approaches produce composite scores rather than a single physical quantity, and the composition differs between systems.

Clinical use

The research interest is concentrated in early detection and in remote monitoring of Parkinson's disease, where fine motor change appears before it is obvious clinically. Passive typing analysis is attractive precisely because it can run continuously without adding assessment burden, and because it produces many observations per day rather than one per visit.

Tapping tasks are used in smartphone based trial batteries as a repeatable motor measure between site visits. Both are reported alongside clinic dexterity tests such as the Nine Hole Peg Test and the Pinch Gauge Test, which measure the same function under supervision, and alongside hand function questionnaires that describe what the impairment costs in daily activity.

Regulatory status

No regulatory qualification as an endpoint. Smartphone motor batteries appear in registered trials as exploratory outcome measures.

Limitations

Passive typing analysis is a substantial privacy undertaking. Keystroke timing can be collected without recording content, but participants are consenting to software observing their typing, and protocols must state clearly that content is not captured and how that is enforced.

Both approaches are confounded by device. Screen size, keyboard type, touch sensitivity and operating system change the measurement, and people switch devices. Typing behaviour also depends on context, posture, mood and what is being typed.

Evidence remains early. Most studies are cross sectional comparisons between patients and controls rather than longitudinal demonstrations that the measure tracks progression or responds to treatment, which is the step that would make it an endpoint rather than a signal.

References

  • Lipsmeier F, et al. Evaluation of smartphone-based testing to generate exploratory outcome measures in a phase 1 Parkinson's disease clinical trial. Mov Disord. 2018. pubmed.ncbi.nlm.nih.gov
  • Arroyo-Gallego T, et al. Detecting motor impairment in early Parkinson's disease via natural typing interaction with keyboards. J Med Internet Res. 2018. pubmed.ncbi.nlm.nih.gov
  • Bot BM, et al. The mPower study, Parkinson disease mobile data collected using ResearchKit. Sci Data. 2016. pubmed.ncbi.nlm.nih.gov
  • Hasan H, et al. The BRadykinesia Akinesia INcoordination (BRAIN) tap test: capturing the sequence effect. Mov Disord Clin Pract. 2019. pubmed.ncbi.nlm.nih.gov
Devices that capture it
Related instruments

Closest counterparts are supervised dexterity tests, the Nine Hole Peg Test and the Pinch Gauge Test, which measure the same fine motor function under observation. ABILHAND describes the difficulty the person reports in everyday manual tasks.

Use case
Monitoring
Collect Finger Tapping and Typing Kinematics and other digital biomarkers in one workflow. Or turn your research into a new digital biomarker?
Capture app based motor testing alongside clinic dexterity measures and patient reported outcomes.

Collect your digital biomarker data in no time all under your own brand

Collect meaningful digital biomarker data from your patients with ease. Our platform connects with wearables, smartphones, and other digital health devices, helping you capture continuous, real world data for research or clinical use all within your own branded experience.

Learn More

Connect your Data Sources

Connect wearables, smartphones, and digital health devices to collect relevant biomarker data directly from your patients.
Learn More
We Guide

Collect Data Continuously

Capture passive and active digital biomarker data such as activity, sleep, heart rate, mobility, and other vital signals over time.
Learn More

Collect the Data that Matters

Collect the digital health data most relevant to your research or clinical program. Choose the measurements and data points that support your specific study objectives and use case.
Learn More

Monitor the Full Patient Journey

Collect longitudinal biomarker data throughout the patient journey, from onboarding and baseline assessment to ongoing monitoring and follow up.
Learn More
Build your own biomarker, gather
evidence and commerclise
support screenshot
Pallete Paints

Rapidly design and configure complex studies in one place.

Set up your study without the technical friction. Easily define and configure all the critical data points you need to collect from patient reported forms and clinical tests to remote wearables using our intuitive, centralised platform.
Clinical Trial Builder

Capture unified, multimodal data with automated workflows.

Utilise WeGuide Engage to build your required dataset effortlessly. Keep participants and clinicians actively involved through automated prompts, ensuring high compliance and consistent data capture across all modalities.
We Guide
We Guide
Toggle Right

Evaluate clinical algorithms instantly with AI powered tools.

Bypass the technical bottlenecks with our biomarker development studio. Seamlessly create, score, and evaluate complex algorithms with the click of a button, turning raw data into validated insights without bespoke coding.
We Guide

Distribute directly via our Class IIb certified platform.

Seamlessly transition from research to revenue. Commercialise your digital biomarker instantly on our regulatory approved infrastructure, making it immediately available for pharma, clinical trials, and real-world interventions.